FDA Approves Two Sickle Cell Disease Gene Therapies
Favicon 
www.newsmax.com

FDA Approves Two Sickle Cell Disease Gene Therapies

The U.S. Food and Drug Administration (FDA) on Friday approved a pair of gene therapies for sickle cell disease‚ including the first treatment based on the breakthrough CRISPR gene editing technology.The agency approved Lyfgenia from bluebird bio‚ and a separate treatment...